title: Does granulocyte colony-stimulating factor improve long-term outcome in adult acute lymphoblastic leukemia?
authors.forename: Helene
authors.initials: H
authors.lastname: Hallböök
authors.forename: Magnus
authors.initials: M
authors.lastname: Björkholm
authors.forename: Hans
authors.initials: H
authors.lastname: Hägglund
authors.forename: Bengt
authors.initials: B
authors.lastname: Smedmyr
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D005260:Female; D005500:Follow-Up Studies; D016179:Granulocyte Colony-Stimulating Factor / Q000008:administration & dosage / Q000235:genetics / Q000627:therapeutic use*; D006801:Humans; D007279:Injections, Subcutaneous; D053208:Kaplan-Meier Estimate; D008297:Male; D008875:Middle Aged; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000188:drug therapy* / Q000473:pathology; D011446:Prospective Studies; D011994:Recombinant Proteins / Q000008:administration & dosage / Q000627:therapeutic use; D013997:Time Factors; D016896:Treatment Outcome; D055815:Young Adult
chemical_list: D011994:Recombinant Proteins; D016179:Granulocyte Colony-Stimulating Factor